Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $71,050 | 31 | 65.1% |
| Unspecified | $17,110 | 4 | 15.7% |
| Food and Beverage | $10,927 | 508 | 10.0% |
| Travel and Lodging | $6,691 | 20 | 6.1% |
| Consulting Fee | $3,390 | 2 | 3.1% |
| Education | $41.70 | 4 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $72,997 | 95 | $0 (2022) |
| Eli Lilly and Company | $17,110 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $3,397 | 8 | $0 (2020) |
| Abbott Laboratories | $3,265 | 65 | $0 (2024) |
| Boston Scientific Corporation | $2,739 | 77 | $0 (2024) |
| Edwards Lifesciences Corporation | $2,455 | 103 | $0 (2024) |
| PORTOLA PHARMACEUTICALS, INC. | $2,103 | 3 | $0 (2018) |
| Medtronic Vascular, Inc. | $1,305 | 53 | $0 (2020) |
| Cardiovascular Systems Inc. | $1,217 | 13 | $0 (2019) |
| Medtronic, Inc. | $410.23 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,445 | 32 | Eli Lilly and Company ($7,902) |
| 2023 | $780.64 | 40 | Edwards Lifesciences Corporation ($221.01) |
| 2022 | $1,517 | 83 | Edwards Lifesciences Corporation ($282.62) |
| 2021 | $10,253 | 49 | Eli Lilly and Company ($9,111) |
| 2020 | $9,536 | 68 | Janssen Pharmaceuticals, Inc ($5,350) |
| 2019 | $27,355 | 92 | Janssen Pharmaceuticals, Inc ($24,533) |
| 2018 | $21,806 | 55 | Janssen Pharmaceuticals, Inc ($19,009) |
| 2017 | $29,517 | 150 | Janssen Pharmaceuticals, Inc ($23,522) |
All Payment Transactions
569 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Boston Scientific Corporation | INGEVITY MRI (Device) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: INGEVITY_CRM | ||||||
| 11/04/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Pacemakers | ||||||
| 10/02/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/27/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Heart Failure | ||||||
| 09/26/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: CDS - BG Mini Plus_RM | ||||||
| 09/23/2024 | Eli Lilly and Company | — | — | Cash or cash equivalent | $7,902.00 | Research |
| Study: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY COMPARING THE EFFICACY AND SAFETY OF TIRZEPATIDE VERSUS PLACEBO IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION AND OBESITY (SUMMIT | ||||||
| 09/16/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $33.66 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/01/2024 | Abbott Laboratories | EPIC (Device) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Structural Heart | ||||||
| 08/01/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $7.16 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/01/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $1.22 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/22/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: Cardiology | ||||||
| 07/22/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Heart Failure | ||||||
| 06/20/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: CDS - BG Mini_RM | ||||||
| 06/04/2024 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Transcatheter Heart Valves | ||||||
| 05/29/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/21/2024 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Transcatheter Heart Valves | ||||||
| 05/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/09/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.01 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/02/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/16/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.48 | General |
| 04/15/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.10 | General |
| Category: Cardiovascular | ||||||
| 04/10/2024 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Transcatheter Heart Valves | ||||||
| 03/10/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Pacemakers | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY COMPARING THE EFFICACY AND SAFETY OF TIRZEPATIDE VERSUS PLACEBO IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION AND OBESITY (SUMMIT | Eli Lilly and Company | $17,110 | 4 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 67 | 5,760 | 7,805 | $2.7M | $763,419 |
| 2022 | 62 | 6,296 | 9,850 | $3.1M | $969,099 |
| 2021 | 63 | 6,482 | 13,991 | $2.9M | $935,231 |
| 2020 | 65 | 6,833 | 13,499 | $2.8M | $927,196 |
All Medicare Procedures & Services
286 procedure records from CMS Medicare Utilization — Page 1 of 12
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 204 | 204 | $520,800 | $174,657 | 33.5% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 185 | 188 | $296,000 | $114,495 | 38.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,027 | 1,143 | $200,025 | $93,163 | 46.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 463 | 580 | $229,145 | $62,141 | 27.1% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 25 | 25 | $140,000 | $45,398 | 32.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 211 | 844 | $105,500 | $36,770 | 34.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 203 | 203 | $55,825 | $22,350 | 40.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 161 | 201 | $80,500 | $21,712 | 27.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 176 | 188 | $47,000 | $18,886 | 40.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 285 | 291 | $34,920 | $16,893 | 48.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 44 | 53 | $52,800 | $14,206 | 26.9% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 200 | 200 | $40,000 | $10,530 | 26.3% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 59 | 71 | $39,000 | $10,073 | 25.8% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 21 | 23 | $34,500 | $9,722 | 28.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 69 | 204 | $31,416 | $8,429 | 26.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 153 | 159 | $29,415 | $8,371 | 28.5% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 44 | 45 | $29,250 | $7,858 | 26.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 59 | 84 | $15,120 | $5,164 | 34.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 424 | 461 | $20,745 | $4,650 | 22.4% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 45 | 48 | $27,450 | $4,586 | 16.7% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 72 | 207 | $15,525 | $4,292 | 27.6% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 63 | 73 | $9,125 | $3,920 | 43.0% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 75 | 95 | $17,100 | $3,785 | 22.1% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 33 | 43 | $15,080 | $3,688 | 24.5% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 49 | 99 | $11,484 | $3,406 | 29.7% |
About Dr. Mark Fasulo, MD
Dr. Mark Fasulo, MD is a Internal Medicine healthcare provider based in Beaumont, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2009. The National Provider Identifier (NPI) number assigned to this provider is 1366686487.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Fasulo, MD has received a total of $109,209 in payments from pharmaceutical and medical device companies, with $8,445 received in 2024. These payments were reported across 569 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($71,050).
As a Medicare-enrolled provider, Fasulo has provided services to 25,371 Medicare beneficiaries, totaling 45,145 services with total Medicare billing of $3.6M. Data is available for 4 years (2020–2023), covering 286 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Beaumont, TX
- Active Since 04/21/2009
- Last Updated 03/28/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1366686487
Products in Payments
- XARELTO (Drug) $72,997
- FARXIGA (Drug) $3,367
- BEVYXXA (Drug) $2,103
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $1,420
- GENERAL - VASCULAR ACCESS (Device) $1,281
- Micra (Device) $1,153
- Xience V coronary stent system (Device) $987.06
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $882.95
- Coronary Orbital Atherectomy System (Device) $810.06
- RESONATE (Device) $460.87
- CRT-Ds (Device) $395.49
- ELIQUIS (Drug) $313.14
- Confirm Rx (Device) $282.21
- Assurity Pacemaker (Device) $231.71
- Mitra Clip system (Device) $204.18
- MRI Ready Leads (Device) $201.71
- Endurity Pacemaker (Device) $175.62
- Allure CRT Pacemaker (Device) $174.02
- Repatha (Biological) $162.22
- VERQUVO (Drug) $157.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Beaumont
Dr. Salem Salem, M.d, M.D
Internal Medicine — Payments: $109,385
Dr. Russell Perry, Md, MD
Internal Medicine — Payments: $100,450
Dr. William Burkes, M.d, M.D
Internal Medicine — Payments: $97,221
Dr. Allen Mcgrew, D.o, D.O
Internal Medicine — Payments: $27,220
Dr. Mohammad Alghrouz, Md, MD
Internal Medicine — Payments: $12,639
Msonthi Levine, Md, MD
Internal Medicine — Payments: $12,402